Boehringer Ingelheim Corporate Website: Human Pharmaceuticals and Consumer Health Care, Animal Health Business

No flash player detected. For optimized usage of this website your browser should support shockwave flash. For downloading see Macromedia Flash Player

Top Links

Latest News Releases

27.11.2009Major European regulatory milestone in cardiovascular protection for Micardis^® (telmisartan): Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients
For medical media, outside the US only
16.11.2009Flibanserin demonstrates efficacy and tolerability in pivotal Phase III Trials in pre-menopausal women with Hypoactive Sexual Desire Disorder (HSDD)
For medical media, outside the US only

News items

Our Global Activities

Worldmap

Upcoming Event

RE-COVER™ Results

read more

Latest event

The Science of Desire: New Discoveries in HSDD

read more